Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

Functions of Thyroid Hormones

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort.

Endocrine·2021

Same author

Response to Letter on use of functional imaging by 11C-metomidate PET for primary aldosteronism subtyping.

European journal of endocrinology·2021

Same author

Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.

European journal of endocrinology·2020

Same author

Osteosclerosis associated with hepatitis C.

Duodecim; laaketieteellinen aikakauskirja·2017

Same author

C-myc expression in adrenocortical tumours.

Journal of clinical pathology·2017

Same author

Long-Term Effect of Gastric Bypass and Sleeve Gastrectomy on Severe Obesity: Do Preoperative Weight Loss and Binge Eating Behavior Predict the Outcome of Bariatric Surgery?

Obesity surgery·2016

Same journal

Update on Current Care Guideline: Psoriasis (skin and joints).

Duodecim; laaketieteellinen aikakauskirja·2017

Same journal

FOUR score in monitoring the level of consciousness of an intensive care patient: first experience of the use of the Finnish language version.

Duodecim; laaketieteellinen aikakauskirja·2017

Same journal

Discussing a serious illness with a patient and family.

Duodecim; laaketieteellinen aikakauskirja·2017

Same journal

Invasive treatment of superficial veins of the lower extremities.

Duodecim; laaketieteellinen aikakauskirja·2017

Same journal

When should a drain be left in the abdominal cavity upon surgery?

Duodecim; laaketieteellinen aikakauskirja·2017

Same journal

Diagnostics and current care of myasthenia gravis.

Duodecim; laaketieteellinen aikakauskirja·2017

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

[No thyroxin dose seemed sufficient--why?].

Kalevi Laitinen¹, Timo Sane, Samuel Fanta

¹HYKS:n naistenklinikka PL 140, 00029 HUS.

Duodecim; Laaketieteellinen Aikakauskirja

|August 15, 2009

Summary

This summary is machine-generated.

A pregnant woman with type 1 diabetes experienced increasing proteinuria and required higher thyroxine doses due to hypothyroidism. Doctors discovered thyroxine was being secreted into her urine, a rare but significant complication.

Related Experiment Videos

Last Updated: Jun 21, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Area of Science:

Endocrinology
Nephrology
Maternal-Fetal Medicine

Background:

Case study of a pregnant woman with type 1 diabetes and hypothyroidism secondary to Graves' disease.
Management involved insulin and thyroxine therapy.
Complications included diabetic nephropathy and significant proteinuria.

Observation:

Proteinuria levels increased substantially during pregnancy.
Thyroxine dosage escalated to exceptionally high levels.
Investigation revealed thyroxine secretion into the urine.

Findings:

The primary cause for increased thyroxine requirements was urinary thyroxine loss.
This phenomenon, though previously documented, is not widely recognized in clinical practice.
Highlights a potential complication in managing hypothyroidism during pregnancy in diabetic patients with nephropathy.

Implications:

Clinicians should consider urinary thyroxine loss in pregnant patients with diabetes, nephropathy, and escalating thyroxine needs.
This case underscores the importance of monitoring thyroid hormone levels and renal function closely in this patient population.
Further research may be warranted to understand the prevalence and mechanisms of thyroxineuria in pregnancy.